PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 276 filers reported holding PACIRA PHARMACEUTICALS INC in Q2 2024. The put-call ratio across all filers is 3.96 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $217,664 | -22.8% | 7,608 | -21.1% | 0.01% | -17.6% |
| Q1 2024 | $281,885 | -67.9% | 9,647 | -62.9% | 0.02% | -69.1% |
| Q4 2023 | $877,712 | +22.2% | 26,014 | +11.1% | 0.06% | +17.0% |
| Q3 2023 | $718,218 | -27.5% | 23,410 | -5.4% | 0.05% | -17.5% |
| Q2 2023 | $991,210 | -1.2% | 24,737 | +0.6% | 0.06% | -6.6% |
| Q1 2023 | $1,003,721 | +106678.8% | 24,595 | +1.0% | 0.06% | +5.2% |
| Q4 2022 | $940 | -99.9% | 24,341 | -3.2% | 0.06% | -33.3% |
| Q3 2022 | $1,337,000 | -8.0% | 25,141 | +0.8% | 0.09% | -1.1% |
| Q2 2022 | $1,454,000 | -24.2% | 24,953 | -0.7% | 0.09% | -10.2% |
| Q1 2022 | $1,919,000 | +36.0% | 25,140 | +7.2% | 0.10% | +44.1% |
| Q4 2021 | $1,411,000 | +9.4% | 23,452 | +1.8% | 0.07% | +4.6% |
| Q3 2021 | $1,290,000 | +110.8% | 23,038 | +163.9% | 0.06% | +103.1% |
| Q2 2021 | $612,000 | 0.0% | 8,730 | 0.0% | 0.03% | 0.0% |
| Q1 2021 | $612,000 | +4.6% | 8,730 | -10.8% | 0.03% | 0.0% |
| Q4 2020 | $585,000 | +10.2% | 9,782 | +10.7% | 0.03% | -3.0% |
| Q3 2020 | $531,000 | – | 8,835 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tamarack Advisers, LP | 273,000 | $8,818,000 | 6.24% |
| Standard Investments LLC | 775,388 | $25,045,000 | 4.58% |
| ARMISTICE CAPITAL, LLC | 400,000 | $12,920,000 | 3.06% |
| HealthCor Management, L.P. | 1,575,000 | $50,873,000 | 2.88% |
| DARUMA CAPITAL MANAGEMENT LLC | 1,219,642 | $39,394,000 | 2.24% |
| Consonance Capital Management LP | 631,805 | $20,407,000 | 2.24% |
| Rock Springs Capital Management LP | 713,000 | $23,030,000 | 1.54% |
| Biondo Investment Advisors, LLC | 142,473 | $4,602,000 | 1.52% |
| Opus Point Partners Management, LLC | 50,000 | $1,615,000 | 1.29% |
| Partner Investment Management, L.P. | 26,690 | $862,000 | 1.14% |